We conclude that participants with low HRQoL are more likely to have lower adherence to antihypertensive medications. Thus, low HRQoL may be an important barrier to achieving high rates of adherence to treatment. These study findings could be helpful in clinical practice, mainly in the early treatment of hypertensive patients, at a point where improving HRQoL is still possible. Further research is needed to clarify the longitudinal relationship between HRQoL, antihypertensive medication adherence and health outcomes among hypertensive patients and to verify whether improvements in quality of life can lead to high rates of adherence to antihypertensive medication and improvements in outcome by preventing or reducing the incidence of CVDs.
Journal
Title
International Journal of Cardiology Volume 168, Issue 3, 3 October 2013, Pages 2981–2983
